Vladimirsky, (5)Hepatolog Medical Company, (6)Fsbi National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, (7)Gilead Sciences, Inc., (8)Modern Medicine Clinic, (9)Goethe University Hospital, (10)Hannover Medical School, (11)Service Hpato-Gastro-Entrologie, Hpital Saint-Joseph, (12)Hpatologie Unit, Hospices Civils De Lyon, Lyon University, Inserm, (13)Hpital Beaujon Aphp, Universit De Paris, Inserm, (14)Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, (15)Heidelberg University Hospital, Clinical Pharmacology and Pharmacoepidemiology Background: Bulevirtide (BLV), a novel entry inhibitor, is approved in Europe for chronic hepatitis delta (CHD) treatment
Bram V, Stefania V, Azucena S, Shadi N, Marjolijn D, Niels VC
Chronic kidney disease (CKD) is a prevalent chronic progressive disease characterized by abnormal kidney structure and dysfunction resulting from various underlying conditions
Doctors experience Experienced dermatologists charge high counseling and treatment fees but provide safe and more effective care
Trends Pharmacol Sci (2018) 39(5):51324
Dopamine agonists exhibit efficacy in managing PD symptoms but can be associated with sedation, visual hallucinations, euphoria, and psychosis, potentially leading to delirium (76, 77)